Akers Biosciences Gross Profit

Akers Biosciences (AKER) currently reports a gross profit of $-130K as of December 2020. That compares with $1.1M in the prior-year period — down 112.4% year over year. That is below the Healthcare sector average of $67B. Use the charts on this page to explore Akers Biosciences's gross profit history and peer comparisons.

Akers Biosciences's gross profit decreased from $1.1M to $-130K — a 112.4% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akers Biosciences's gross profit of $-130K is lower than the Healthcare sector average of $67B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Akers Biosciences reported $-130K in gross profit as of December 2020. That compares with $1.1M in the prior-year period — down 112.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $-130K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $67B. From there, open related valuation or income-statement pages for Akers Biosciences, and consider following AKER for alerts when major investors trade the stock.